Enzolytics Inc (ENZC)

[Thorfius]

I'm not going to argue with how they're funding everything. Seems one of the two is inevitable.

However, my question is this - If they're just going to be bought directly following the audit, why make a big deal about uplisting to OTCQB and forming a new subsidiary in Bulgaria (IMPL) for trials? Wouldn't that insinuate that the company expects to remain operating as they currently are for the foreseeable future?

Legitimate question, not a rhetorical question. Thanks!